Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
CEN BIOTECH INC (CENBF) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/29/2023 8-K Quarterly results
09/16/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CEN Biotech Inc. Announces the Pending Launch of WordPresto"
09/07/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CEN Biotech Inc. Shares To Commence Trading on the OTCQB Venture Market® Windsor, ON – September 7, 2022 – CEN Biotech Inc. , a global holding company focused on the development of leading-edge digital media technologies, LED lighting technology and hemp-based products announced that as of September 8, 2022, its common shares will begin trading on the OTCQB Venture Market® under the symbol "CENBF". The OTCQB Venture Market, operated by OTC Markets Group Inc., is for entrepreneurial and development stage U.S. and international companies. To be eligible to trade on the OTCQB Venture Market, companies must meet certain standards, including being current in their reporting obligations and undergoing an annual verification and management certification process. Companies must also meet $0.01 bid..."
08/31/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN LAWRENCE LEHOUX AND CEN BIOTECH, INC.",
"EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN BRIAN S. PAYNE AND CEN BIOTECH, INC.",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT",
" ",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENT"
07/20/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/26/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/21/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: " ",
" ",
" ",
" ",
" ",
" "
04/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "From:",
"From: Alex Tarrabain Sent: Thursday, April 14, 2022 7:48:23 PM To: Brian Payne Subject: Resignation Brian Payne, Effective immediately I, Alex Tarrabain, hereby resign from my position as Vice President & CFO of Cenbiotech Inc. I also resign from my duties as Director of the Board all other roles. I would like congratulate Brian Payne on his new role as CEO, CFO, Chairman of the Board and Principal Executive and Accounting Officer With kindest regards, Alex Tarrabain Work: 780-468-1898 Fax: 780-468-9354 Email: [email protected]",
"From:",
" ",
"From:"
12/08/2021 8-K Quarterly results
10/13/2021 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "10.2",
"99.1*",
"CEN Biotech Inc. Announces the Closing of LED Patent Acquisition Windsor, ON – October 13, 2021 – CEN Biotech Inc. , a global holding company focused on the manufacturing, production and development of LED lighting technology and hemp-based products intended to help improve your state of health and well-being, is pleased to announce that it is has consummated the transaction for Patent Number U.S. 8,723,425 . On October 7, 2021, CEN entered into an Asset Purchase Agreement in connection with the purchase and acquisition of the right, title, and interest in and to the Patent, as more particularly described in the APA and related transaction documents. Pursuant to the Agreement, Tesla Digital, Inc., Tesla Digital Global Group, Inc. and Stevan Pokrajac are to receive 5,000,000 shares of CEN c..."
09/17/2021 8-K/A Quarterly results
07/16/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN",
"CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN"
07/13/2021 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Employment Agreement with Lawrence Lehoux",
"Audited Financial Statements of Clear Com Media Inc. for the years ended December 31, 2020 and 2019 and Unaudited Interim Financial Statements of Clear Com Media Inc. for the quarter ended March 31, 2021",
"CEN Biotech Inc. Announces Planned Strategic Expansion of Business and closing of Clear Com Media Inc. Acquisition Windsor, ON – July 12, 2021 – CEN Biotech Inc. , a global holding company focused on the manufacturing, production and development of LED lighting technology and hemp-based products intended to help improve your state of health and well-being, is pleased to announce that it is seeking to expand its business to include Cannabis, Psychedelic Mushrooms, and Digital Communities. CEN Biotech’s mission is to strive to be an agriculture based mindful provider of Phyto medical solutions developed to help improve "your" state of health and well-being. Our vision as a biotech company is to focus on Quality, Reliability and Transparency in all that we do while aiming to produce and deliv..."
06/25/2021 8-K Quarterly results
04/20/2021 8-K Quarterly results
04/19/2021 8-K Quarterly results
04/08/2021 8-K Quarterly results
04/07/2021 8-K Quarterly results
04/05/2021 8-K Quarterly results
05/20/2020 8-K/A Financial Statements and Exhibits
Docs: "Termination and Release Agreement"
05/12/2020 8-K Quarterly results
03/17/2020 8-K Quarterly results
01/28/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CEN BiotechInc. Market Maker Files 15c211 for CEN Biotech Inc. WINDSOR, ON, January 28, 2020 - A market maker has filed a Form 211 Application with the Financial Industry Regulatory Authority to request permission to quote and trade the securities of CEN Biotech, Inc. on OTC Markets. CEN Biotech is a Global Holding company focusing on Hemp , functional and innovative foods, nutrition, and cutting edge advancements in LED Lighting technology. The Form 211 Application must be approved by FINRA in order to receive a ticker symbol and begin trading. CEN Biotech intends to submit an application to have its common stock quoted on OTC Markets as soon as practicable after the Form 211 Application is approved. However, there can be no assurance that FINRA will approve our Form 211 Application, and ..."
11/27/2019 8-K Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CEN Biotech Announces the Termination of Merger Agreement"
11/18/2019 8-K Quarterly results
08/29/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Merger Agreement, by and between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc",
"Amendment No. 2 to Merger Agreement, by and between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc",
"Update on Merger Agreement with Caduceus Software Systems Corp. WINDSOR, ON, August 29, 2019 – On June 21, 2019, CEN Biotech, Inc. entered into a Merger Agreement with Caduceus Software Systems Corp., a Wyoming corporation and Caduceus Merger Sub, Inc., a Wyoming corporation and a wholly owned subsidiary of CSOC . Pursuant to the Merger Agreement, CEN, the Merger Sub and CSOC agreed to effect a merger transaction, pursuant to which CEN will merge with and into the Merger Sub, with CEN surviving and being a wholly owned subsidiary of CSOC . Pursuant to the Merger Agreement, it was planned that the Merger, the Merger Agreement and the transactions contemplated thereby would close on or around August 30, 2019, subject to the satisfaction of certain conditions and covenants set forth in the Me..."
06/21/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Form of Merger Agreement dated June 21, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc",
"WINDSOR, ON, June 21, 2019 – On June 21, 2019, CEN Biotech, Inc. entered into a Merger Agreement with Caduceus Software Systems Corp., a Wyoming corporation , which was reviewed and approved by the Board of Directors of CEN on June 21, 2019. This transaction follows the signing of a Non-Binding Term Sheet with CSOC on May 15, 2019, in which, CEN and CSOC agreed to undertake a merger transaction to combine the two companies’ operations and negotiate and enter into a definite agreement to affect the transaction. According to Joseph Byrne, CEO of CEN Biotech Inc., “We believe that this Merger Agreement is a major milestone in completing the transaction with CSOC to create a combined company that, we believe, can create value for both CEN and CSOC shareholders.” According to the signed Merger ..."
05/22/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Email Letter to Convertible Note Holders (furnished herewith)"
05/16/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Term Sheet dated May 15, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp",
"WINDSOR, ON, May 16, 2019 – On May 15, 2019, CEN Biotech, Inc. entered into a Non-Binding Term Sheet with Caduceus Software Systems Corp., a Wyoming corporation , which was reviewed and approved by the Board of Directors of CEN on May 15, 2019. Pursuant to the Term Sheet, CEN and CSOC agreed to undertake a merger transaction to combine the two companies’ operations and negotiate and enter into a definite agreement to affect the transaction. According to Joseph Byrne, CEO of CEN Biotech Inc., “It is planned that CEN and CSOC will engage in a merger transaction whereby CSOC will create a new wholly owned subsidiary and CEN will become a wholly owned subsidiary of CSOC. We are very pleased with the direction of this transaction and we believe that it will create value for both CEN and CSOC sh..."
05/16/2019 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Executive Employment Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain",
"Restricted Stock Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain"
04/08/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment dated April 3, 2019, to Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, as amended, between CEN Biotech, Inc. and Stevan Pokrajac and Tesla Digital Inc. and Tesla Digital Global Group Inc"
11/30/2018 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Share Repurchase Agreement, executed as of November 27, 2017, by and between James L. Robinson and CEN Biotech Inc"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy